IF 1.3 Q4 ENDOCRINOLOGY & METABOLISM
Diabetology International Pub Date : 2025-02-03 eCollection Date: 2025-04-01 DOI:10.1007/s13340-025-00802-4
Tomofumi Takayoshi, Yushi Hirota, Akane Yamamoto, Kai Yoshimura, Seiji Nishikage, Mariko Ueda, Wataru Ogawa
{"title":"Impact of a COVID-19 emergency declaration on blood glucose levels in individuals with type 1 diabetes treated with a sensor-augmented pump.","authors":"Tomofumi Takayoshi, Yushi Hirota, Akane Yamamoto, Kai Yoshimura, Seiji Nishikage, Mariko Ueda, Wataru Ogawa","doi":"10.1007/s13340-025-00802-4","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>COVID-19 emergency declarations and ensuing lockdowns affected lifestyle and glycemic control in individuals with diabetes mellitus, with some studies finding improvement and others deterioration of glucose management. The effects of such emergency declarations in Asian populations, including individuals with type 1 diabetes (T1D) managed with a sensor-augmented pump (SAP), have been unclear, however. We here investigated the impact of a COVID-19 emergency declaration on glycemic control in Japanese individuals with T1D treated with a SAP device.</p><p><strong>Methods: </strong>This retrospective investigation included individuals with T1D who were managed with SAP technology and had continuous glucose monitoring including sensor glucose levels and time above range, time in range [TIR], and time below range and insulin dose data available in electronic health records from February to July 2020, corresponding to periods before, during, and after the declared emergency.</p><p><strong>Results: </strong>The 78 enrolled individuals had a mean age of 44.6 years, diabetes duration of 15.4 years, and hemoglobin A<sub>1c</sub> level of 7.3%. Average sensor glucose levels improved from 152.0 mg/dL before to 148.0 mg/dL during and 147.6 mg/dL after the emergency. TIR increased from 68.8% before to 71.3% during and 71.4% after the emergency. Total daily insulin dose decreased from 40.9 U before to 39.6 U after the emergency. After the emergency declaration, individuals with an initial TIR of ≤ 70% showed increased sensor adherence as well as a greater improvement in glycemic control compared with those with a TIR of > 70%.</p><p><strong>Conclusion: </strong>Individuals with T1D treated with a SAP device showed improved glycemic management after the COVID-19 emergency declaration.</p><p><strong>Supplementary information: </strong>The online version contains supplementary material available at 10.1007/s13340-025-00802-4.</p>","PeriodicalId":11340,"journal":{"name":"Diabetology International","volume":"16 2","pages":"379-384"},"PeriodicalIF":1.3000,"publicationDate":"2025-02-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11954778/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diabetology International","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s13340-025-00802-4","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/4/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

摘要

导言:COVID-19紧急状态声明和随之而来的封锁影响了糖尿病患者的生活方式和血糖控制,一些研究发现血糖管理有所改善,而另一些研究则发现血糖管理有所恶化。然而,在亚洲人群中,包括使用传感器增强泵(SAP)管理的 1 型糖尿病(T1D)患者中,此类紧急声明的影响尚不明确。我们在此研究了 COVID-19 紧急声明对使用 SAP 设备治疗的日本 1 型糖尿病患者血糖控制的影响:这项回顾性调查的对象包括使用 SAP 技术进行治疗的 T1D 患者,他们在 2020 年 2 月至 7 月期间的电子健康记录中提供了连续血糖监测数据,包括传感器血糖水平、高于范围的时间、在范围内的时间 [TIR]、低于范围的时间以及胰岛素剂量数据,这些数据分别对应于宣布紧急情况之前、期间和之后的时间段:78 名参加者的平均年龄为 44.6 岁,糖尿病病程为 15.4 年,血红蛋白 A1c 水平为 7.3%。传感器的平均血糖水平从应急前的 152.0 毫克/分升降至应急期间的 148.0 毫克/分升和应急后的 147.6 毫克/分升。TIR 从急救前的 68.8%增至急救期间的 71.3%和急救后的 71.4%。每日胰岛素总剂量从紧急状况前的 40.9 U 下降到紧急状况后的 39.6 U。紧急状况宣布后,与TIR>70%的患者相比,初始TIR≤70%的患者对传感器的依从性有所提高,血糖控制也得到了更大改善:结论:使用SAP设备治疗的T1D患者在COVID-19紧急声明后血糖控制情况有所改善:在线版本包含补充材料,可在10.1007/s13340-025-00802-4上查阅。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Impact of a COVID-19 emergency declaration on blood glucose levels in individuals with type 1 diabetes treated with a sensor-augmented pump.

Introduction: COVID-19 emergency declarations and ensuing lockdowns affected lifestyle and glycemic control in individuals with diabetes mellitus, with some studies finding improvement and others deterioration of glucose management. The effects of such emergency declarations in Asian populations, including individuals with type 1 diabetes (T1D) managed with a sensor-augmented pump (SAP), have been unclear, however. We here investigated the impact of a COVID-19 emergency declaration on glycemic control in Japanese individuals with T1D treated with a SAP device.

Methods: This retrospective investigation included individuals with T1D who were managed with SAP technology and had continuous glucose monitoring including sensor glucose levels and time above range, time in range [TIR], and time below range and insulin dose data available in electronic health records from February to July 2020, corresponding to periods before, during, and after the declared emergency.

Results: The 78 enrolled individuals had a mean age of 44.6 years, diabetes duration of 15.4 years, and hemoglobin A1c level of 7.3%. Average sensor glucose levels improved from 152.0 mg/dL before to 148.0 mg/dL during and 147.6 mg/dL after the emergency. TIR increased from 68.8% before to 71.3% during and 71.4% after the emergency. Total daily insulin dose decreased from 40.9 U before to 39.6 U after the emergency. After the emergency declaration, individuals with an initial TIR of ≤ 70% showed increased sensor adherence as well as a greater improvement in glycemic control compared with those with a TIR of > 70%.

Conclusion: Individuals with T1D treated with a SAP device showed improved glycemic management after the COVID-19 emergency declaration.

Supplementary information: The online version contains supplementary material available at 10.1007/s13340-025-00802-4.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Diabetology International
Diabetology International ENDOCRINOLOGY & METABOLISM-
CiteScore
3.90
自引率
4.50%
发文量
42
期刊介绍: Diabetology International, the official journal of the Japan Diabetes Society, publishes original research articles about experimental research and clinical studies in diabetes and related areas. The journal also presents editorials, reviews, commentaries, reports of expert committees, and case reports on any aspect of diabetes. Diabetology International welcomes submissions from researchers, clinicians, and health professionals throughout the world who are interested in research, treatment, and care of patients with diabetes. All manuscripts are peer-reviewed to assure that high-quality information in the field of diabetes is made available to readers. Manuscripts are reviewed with due respect for the author''s confidentiality. At the same time, reviewers also have rights to confidentiality, which are respected by the editors. The journal follows a single-blind review procedure, where the reviewers are aware of the names and affiliations of the authors, but the reviewer reports provided to authors are anonymous. Single-blind peer review is the traditional model of peer review that many reviewers are comfortable with, and it facilitates a dispassionate critique of a manuscript.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信